Clinical Trials Browser

Plasmablastic Lymphoma × daratumumab × Clear all

NCT04915248 2025-12-24

FIL_DALYA

Phase 2 Recruiting

Plasmablastic Lymphoma, Lymphoma, Recurrence

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma